LianBio
China · $313.0M raised
- Business Model
- B2B
- Total Funding
- $313.0M
- Last Round
- $3.0M Venture RoundOct 2020
- Rounds
- 2
About
Biotechnology company developing and commercializing innovative therapies in China and major Asian markets.
Summary
LianBio is a Biotech company based in China. It has raised $313.0M in total across 2 rounds, most recently a $3.0M Venture Round round in Oct 2020. Investors include RA Capital, Venrock Healthcare Partners and Pfizer Ventures.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Oct 2020
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...